Fact checked byGina Brockenbrough, MA

Read more

October 29, 2022
1 min read
Save

DePuy Synthes receives FDA 510(k) clearance of MIS lumbar interbody fusion platform

Fact checked byGina Brockenbrough, MA
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

DePuy Synthes has announced FDA 510(k) clearance of the Teligen system, a platform of digital tools for minimally invasive transforaminal lumbar interbody fusion procedures, according to a company press release.

The Teligen platform is designed to offer surgeons enhanced visualization, access and control for minimally invasive surgical transforaminal lumbar interbody fusion (MIS-TLIF) procedures. The system is comprised of a high-definition disposable camera control system, a discectomy device and patient-based disposable ports, according to the release.

FDA HQ in Washington
Source: Adobe Stock

“Improving the MIS spinal surgery experience for both patients and surgeons is a critical step to addressing unmet needs in the industry,” Russell Powers, worldwide president of spine at DePuy Synthes, said in the release. “With our groundbreaking Teligen technology platform, we're providing a better field of view to help improve patient care and increase efficiencies.”